Workflow and factors associated with delay in the delivery of intra-arterial treatment for acute ischemic stroke in the MR CLEAN trial

  • Esmee Venema*
  • , Nikki Boodt
  • , Olvert A. Berkhemer
  • , Pleunie P. M. Rood
  • , Wim H. van Zwam
  • , Robert J. van Oostenbrugge
  • , Aad van der Lugt
  • , Yvo B. W. E. M. Roos
  • , Charles B. L. M. Majoie
  • , Hester F. Lingsma
  • , Diederik W. J. Dippel
  • , MR CLEAN Investigators
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective The effect of intra-arterial treatment (IAT) for acute ischemic stroke is highly time-dependent. We investigated the delay of IAT and factors associated with such delay. Methods MR CLEAN was a randomized trial of IAT plus usual care versus usual care alone (n=500). With multivariable linear regression, we analyzed the effect of intravenous treatment, general anesthesia, off-hours and inter-hospital transfer on time to admission to the emergency department (ED) of the intervention center and time to treatment. Furthermore, we assessed compliance with a target of 75min for time from ED to treatment, and calculated the potential absolute increase in the number of patients with a good outcome (modified Rankin Scale score <= 2) if this target had been achieved in all treated patients. Results Inter-hospital transfer prolonged time to ED by 140min (95% CI 129 to 150) but reduced time from ED to treatment by 77min (95% CI 64 to 91). Time from ED to treatment was increased by 19min by general anesthesia (95% CI 5 to 33) and total time was increased by 23min during off-hours (95% CI 6 to 40). The in-hospital target was achieved in 11.5% (22/192) of patients. Full compliance with the target time of 75min from ED to treatment would have increased the proportion of patients with a good outcome by 7.6% (95% CI 6.7% to 8.5%). Conclusion Inter-hospital transfer is an important cause of delay in the delivery of IAT and every effort should be made to avoid transfers and reduce transfer-related delay. Furthermore, in-hospital workflow should be optimized to improve functional outcome after IAT.
Original languageEnglish
Pages (from-to)424-U19
Number of pages6
JournalJournal of Neurointerventional Surgery
Volume10
Issue number5
DOIs
Publication statusPublished - 30 Aug 2017

Keywords

  • stroke
  • thrombectomy
  • RANDOMIZED CONTROLLED-TRIAL
  • ENDOVASCULAR TREATMENT
  • INTERVENTIONAL MANAGEMENT
  • CLINICAL-TRIAL
  • TIME
  • THROMBECTOMY
  • REPERFUSION
  • OCCLUSION
  • THERAPY
  • SCALE

Fingerprint

Dive into the research topics of 'Workflow and factors associated with delay in the delivery of intra-arterial treatment for acute ischemic stroke in the MR CLEAN trial'. Together they form a unique fingerprint.

Cite this